跳至主要内容
临床试验/JPRN-UMIN000031259
JPRN-UMIN000031259尚未招募未知

Glucocorticoid-tapering aimed maintenance therapy in patients with systemic lupus erythematosus - BLISS-POST

First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan0 个研究点目标入组 100 人开始时间: 2018年3月1日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • a) Patients who contraindicated by package insert of BLM. b) Receipt of B cell depleted therapy (biologic agent) within 1 year. c) Receipt of cyclophosphamide (Endoxan) within 6 months. d) Receipt of high dose GC (prednisolone equivalent 1mg/kg) within 6 months. e) Receipt of plasma exchange within 6 months. f) Have developed clinical evidence of significant, unstable or uncontrolled, acute or chronic diseases not due to SLE (i.e., cardiovascular, pulmonary, hematologic, gastrointestinal, hepatic, renal, neurological, malignancy or infectious diseases). g) Have developed any other medical diseases (e.g., cardiopulmonary), laboratory abnormalities, or conditions (e.g., poor venous access) that in the opinion of the principal investigator, makes the subject unstable for the study.

研究者

发起方
First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan

相似试验